CHRS, US19247A1007

Coherus BioSciences stock holds at USD 1.56 after a weak session

Published on 09/22/2026 at 15:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Coherus BioSciences stock closed at USD 1.56 on September 21, 2026, down 3.11 percent. The Nasdaq-listed company reported 2025 revenue of USD 254.8 million.

CHRS, US19247A1007, Illustration mit AI erstellt.

Coherus BioSciences, Inc. (US19247A1007) closed at USD 1.56 on Nasdaq on September 21, 2026, down USD 0.05, or 3.11 percent, from the previous close. The latest quoted session also recorded a high of USD 1.66, a low of USD 1.55 and volume of 70,018 shares.

Revenue remains the key reference

Coherus reported revenue of USD 254.8 million for fiscal year 2025, according to the company's investor-relations materials. That figure provides the latest annual operating reference visible in the available company context, while the share price remains close to the lower end of its recent trading range.

The stock's September 21, 2026 close was USD 0.90 below the session high of USD 2.46 shown in the same historical quote context, a difference of 36.6 percent. For investors, the comparison highlights how strongly the valuation depends on updates to revenue, product sales and the company's cash position.

Nasdaq trading stays volatile

The September 21, 2026 quote of USD 1.56 came with 70,018 shares traded, compared with the session range of USD 1.55 to USD 1.66. The 7.03 percent spread between the low and high shows that a small biotechnology stock can move materially within one session even without a large absolute price change.

Coherus operates in biopharmaceuticals, where revenue timing is influenced by product launches, market access and commercial execution. The annual revenue figure of USD 254.8 million and the latest USD 1.56 Nasdaq close therefore belong together: operating progress must translate into repeatable sales before the market can assign a more stable valuation.

Coherus stock closes at USD 1.56

Coherus BioSciences stock closed at USD 1.56 on Nasdaq on September 21, 2026. The reference session included a USD 1.55 low, a USD 1.66 high and volume of 70,018 shares.